NewAmsterdam Pharma N.V. (NAMS)

NAMS trades at $28.5, 26.7% above the near-term max pain of $22.5 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($17.5-$97.5), signaling increased put positioning or downside protection. Key magnetic zone at 23 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for NAMS shows a downward trend from 97.5 to 17.5, indicating bearish sentiment or hedging activity. The 237% spread signals divergent expectations across timeframes. Most levels below 28.5 may cap rallies. Strong magnetic level at 23 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.